BioEclipse Therapeutics
Latest round
- Series A
Last raised
- Oct 2019
Total raised
- $12M
Investors
- 5
About BioEclipse Therapeutics
BioEclipse Therapeutics, Inc.Founded in 2006 and headquartered in San Francisco, US, BioEclipse Therapeutics, Inc. specializes in immunotherapy solutions for cancer.BioEclipse Therapeutics™ develops proprietary immunotherapy products aimed at treating advanced cancers, focusing on patients with resistant and recurrent solid tumors. Their key therapies include CRX200, an allogeneic therapy designed for off-the-shelf availability, and CRX100, an autologous therapy currently in Phase 1b clinical trials.BioEclipse Therapeutics™ operates within the biotechnology sector, primarily engaging in B2B transactions with healthcare providers and research institutions that seek innovative solutions for cancer treatment. Revenue generation is anticipated through partnerships with healthcare facilities and the potential commercial sale of proprietary therapies following successful clinical trials and regulatory approvals. plans to enhance its product development and expand its market reach. This includes launching new immunotherapy products and entering new geographic regions, specifically targeting North America and Europe by 2023.
Who invested in BioEclipse Therapeutics
5 investors across 4 rounds
See all investors in BioEclipse Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BioEclipse Therapeutics
Who invested in BioEclipse Therapeutics?
BioEclipse Therapeutics has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioEclipse Therapeutics raised?
BioEclipse Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did BioEclipse Therapeutics last raise money?
BioEclipse Therapeutics's most recent round on record is a Series A, in Oct 2019.
What does BioEclipse Therapeutics do?
BioEclipse Therapeutics is a pharmaceuticals company.
Where is BioEclipse Therapeutics headquartered?
BioEclipse Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like BioEclipse Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at BioEclipse Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like BioEclipse Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.